Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Humacyte (HUMA) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Acellular Tissue Engineered VesselTrauma Injury, Vascular Injury, Arterial InjuryPhase IVNot Yet RecruitingMulticenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting in Patients With Extremity Arterial Injury Requiring Urgent RepairAug 07, 2026―
Acellular Tissue Engineered Vessel, AvfEnd Stage Renal Disease (Esrd)Phase IIIActive Not RecruitingTo Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring HemodialysisApr 28, 2023
Human Acellular Vessel, Arteriovenous Fistula, HemodialysisHemodialysis, End Stage Renal Disease, Renal Failure, Vascular AccessPhase IIIActive Not RecruitingComparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for HemodialysisJun 08, 2017―
Human Acellular VesselPeripheral Artery DiseasePhase IICompletedHumacyte's HAV for Femoro-Popliteal Bypass in Patients With PADAug 25, 2016―
Human Acellular Vessel, Eptfe GraftHemodialysis, End Stage Renal Disease, Renal Failure, Vascular AccessPhase IIICompletedComparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisDec 29, 2015―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Humacyte (HUMA) have in its pipeline
Humacyte HUMA is currently developing the following drugs: Acellular Tissue Engineered Vessel, Acellular Tissue Engineered Vessel, Avf, Human Acellular Vessel, Arteriovenous Fistula, Hemodialysis, Human Acellular Vessel, Human Acellular Vessel, Eptfe Graft. These drug candidates are in various stages of clinical development as the company works toward FDA approval.